Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBelite Bio, Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.35 | -$0.35 | -$0.35 |
| Q2 2025 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q3 2025 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q4 2025 | 1 | -$0.35 | -$0.35 | -$0.35 |
Belite Bio, Inc Earnings Date And Information
Belite Bio, Inc last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.28 earnings per share for the quarter, topping analysts' consensus estimates of $-0.3 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Belite Bio, Inc has generated $-1 earnings per share over the last year ($-1.19 diluted earnings per share) and currently has a price-to-earnings ratio of -64.54. Belite Bio, Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based on prior year's report dates.
Belite Bio, Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 2024 | N/A | -$0.28 | N/A | $0 | $0 |
| 05/29/2024 | Q2 2024 | N/A | -$0.31 | N/A | $0 | $0 |
| 03/30/2024 | Q1 2024 | N/A | -$0.27 | N/A | N/A | $0 |
| 03/11/2024 | Q4 2023 | N/A | -$0.25 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.40 | N/A | N/A | $0 |
| 06/30/2023 | Q2 2023 | N/A | -$0.26 | N/A | N/A | $0 |
| 03/31/2023 | Q1 2023 | -$0.22 | -$0.33 | -0.11 | N/A | $0 |
| 03/31/2023 | Q4 2022 | -$0.22 | -$10,436.92 | -10436.7 | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$0.10 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$0.12 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$0.05 | N/A | N/A | $0 |
| 12/30/2021 | Q4 2021 | N/A | -$0.26 | N/A | N/A | $0 |
| 09/29/2021 | Q3 2021 | N/A | -$0.26 | N/A | N/A | $0 |
| 06/29/2021 | Q2 2021 | N/A | -$0.25 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$0.25 | N/A | N/A | $0 |
| 12/30/2020 | Q4 2020 | N/A | -$0.21 | N/A | N/A | $0 |
| 09/29/2020 | Q3 2020 | N/A | -$0.21 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$0.12 | N/A | N/A | $0 |
| 03/30/2020 | Q1 2020 | N/A | -$0.12 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Belite Bio, Inc Earnings: FAQ's
Belite Bio, Inc has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based offlast year's report dates.
In the previous quarter, Belite Bio, Inc (:BLTE) reported $-0.28 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.3 by $0.02.
The conference call for Belite Bio, Inc's latest earnings report can be listened to online.
The conference call transcript for Belite Bio, Inc's latest earnings report can be read online.
Belite Bio, Inc (:BLTE) has a recorded net income of $-31,632,000.Belite Bio, Inc has generated $-1.19 earnings per share over the last four quarters.
Belite Bio, Inc (:BLTE) has a price-to-earnings ratio of -64.54 and price/earnings-to-growth ratio is -6.62.